Inventor · disambiguated record
Rachel E. Johns
Also filed as: JOHNS RACHEL · JOHNS RACHEL E · JOHNS RACHEL ELIZABETH
11 granted patents·15 pending applications·182 citations·filing 2009–2025
92Inventor score
Top patents by PatentIndex Score
26 records- 0198US11028179B2Anti-transferrin receptor antibodies and uses thereofAVIDITY BIOSCIENCES INC·Filed 2020·Granted Jun 8, 2021·16 cites·20 claims
- 0298US10913800B2Anti-transferrin receptor antibodies and uses thereofAVIDITY BIOSCIENCES INC·Filed 2020·Granted Feb 9, 2021·19 cites·27 claims
- 0398US10787519B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2018·Granted Sep 29, 2020·19 cites·17 claims
- 0498US10550188B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2018·Granted Feb 4, 2020·80 cites·13 claims
- 0597US10487149B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2018·Granted Nov 26, 2019·21 cites·18 claims
- 0696US11834510B2Anti-transferrin receptor antibodies and uses thereofAVIDITY BIOSCIENCES INC·Filed 2021·Granted Dec 5, 2023·4 cites·20 claims
- 0795US10800848B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2018·Granted Oct 13, 2020·7 cites·16 claims
- 0893US9821067B2Lipopeptides for delivery of nucleic acidsMARINA BIOTECH INC·Filed 2015·Granted Nov 21, 2017·7 cites·11 claims
- 0987US9220785B2Lipopeptides for delivery of nucleic acidsMARINA BIOTECH INC·Filed 2012·Granted Dec 29, 2015·9 cites·11 claims
- 1084US2025381286A1Nucleic acid-polypeptide compositions and methods of inducing exon skippingAVIDITY BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1183US2024228646A9Anti-transferrin receptor antibodies and uses thereofAVIDITY BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1279US12351637B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2021·Granted Jul 8, 2025·0 cites·15 claims
- 1379US12234290B2Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2021·Granted Feb 25, 2025·0 cites·23 claims
- 1478US2025171544A1Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1575US2020123261A1Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1669US2017281795A1Nucleic acid-polypeptide compositions and uses thereofAVIDITY BIOSCIENCES LLC·Filed 2017·Application pending·0 cites
- 1769US2025170260A1Nucleic acid-polypeptide compositions and methods of inducing exon skippingAVIDITY BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1862US2010112042A1Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing TherapeuticsMDRNA INC·Filed 2009·Application pending·0 cites
- 1957US2020282074A1Nucleic acid-polypeptide compositions and methods of inducing exon skippingAVIDITY BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 2057US2015073038A1Delivery molecules for therapeuticsMARINA BIOTECH INC·Filed 2014·Application pending·0 cites
- 2151US2013039970A1Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing TherapeuticsMARINA BIOTECH INC·Filed 2012·Application pending·0 cites
- 2251US2017216227A1Delivery molecules for therapeuticsMARINA BIOTECH INC·Filed 2017·Application pending·0 cites
- 2349US2021095283A1Heteroduplex nucleic acid molecules and uses thereofAVIDITY BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 2448US2010240731A1Lipopeptides for delivery of nucleic acidsMDRNA INC·Filed 2010·Application pending·0 cites
- 2547US2012277289A1Activity generating delivery moleculesFAM RENATA·Filed 2010·Application pending·0 cites
- 2645US2015209283A1Processes and compositions for liposomal and efficient delivery of gene silencing therapeuticsMARINA BIOTECH INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rachel E. Johns files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →